Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 22029953)

Published in Psychoneuroendocrinology on October 24, 2011

Authors

E Heyman1, F-X Gamelin, M Goekint, F Piscitelli, B Roelands, E Leclair, V Di Marzo, R Meeusen

Author Affiliations

1: Univ Lille Nord de France, EA4488 'Activité physique, Muscle, Santé', F-59000 Lille, France. elsa.heyman@univ-lille2.fr

Articles citing this

All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis. Curr Top Behav Neurosci (2013) 1.25

A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res (2014) 1.08

BDNF mediates improvements in executive function following a 1-year exercise intervention. Front Hum Neurosci (2014) 1.00

Psychological aspects of diabetes care: Effecting behavioral change in patients. World J Diabetes (2014) 0.99

Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One (2013) 0.98

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Neuropsychopharmacology (2017) 0.95

Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol (2012) 0.94

Exercise effects on sleep physiology. Front Neurol (2012) 0.91

Conclusions about interventions, programs, and approaches for improving executive functions that appear justified and those that, despite much hype, do not. Dev Cogn Neurosci (2015) 0.90

Optimizing the Exercise Prescription for Depression: The Search for Biomarkers of Response. Curr Opin Psychol (2015) 0.88

Mechanisms of exercise-induced hypoalgesia. J Pain (2014) 0.86

Neuromodulation of Aerobic Exercise-A Review. Front Psychol (2016) 0.85

The effect of exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2 diabetes. PLoS One (2012) 0.85

Sex differences in drug addiction and response to exercise intervention: From human to animal studies. Front Neuroendocrinol (2015) 0.83

Monoamines and cortisol as potential mediators of the relationship between exercise and depressive symptoms. Eur Arch Psychiatry Clin Neurosci (2016) 0.82

Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament. PLoS One (2014) 0.82

The Effect of an Acute Bout of Moderate-Intensity Aerobic Exercise on Motor Learning of a Continuous Tracking Task. PLoS One (2016) 0.82

Expression of brain-derived neurotrophic factor, IGF-1 and cortisol elicited by regular aerobic exercise in adolescents. J Phys Ther Sci (2015) 0.82

Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther (2015) 0.82

Increased adult hippocampal neurogenesis is not necessary for wheel running to abolish conditioned place preference for cocaine in mice. Eur J Neurosci (2014) 0.80

Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS One (2014) 0.80

Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des (2014) 0.80

The Effects of Acute Physical Exercise on Memory, Peripheral BDNF, and Cortisol in Young Adults. Neural Plast (2016) 0.79

What keeps a body moving? The brain-derived neurotrophic factor val66met polymorphism and intrinsic motivation to exercise in humans. J Behav Med (2014) 0.79

The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease. Mov Disord (2015) 0.79

Intensity of anxiety is modified via complex integrative stress circuitries. Psychoneuroendocrinology (2015) 0.78

Voluntary running in young adult mice reduces anxiety-like behavior and increases the accumulation of bioactive lipids in the cerebral cortex. PLoS One (2013) 0.77

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder. Transl Psychiatry (2015) 0.76

Endocannabinoids as Guardians of Metastasis. Int J Mol Sci (2016) 0.75

Physical activity levels determine exercise-induced changes in brain excitability. PLoS One (2017) 0.75

Exercise as an adjunctive treatment for cannabis use disorder. Am J Drug Alcohol Abuse (2016) 0.75

Parameters for abolishing conditioned place preference for cocaine from running and environmental enrichment in male C57BL/6J mice. Behav Brain Res (2016) 0.75

Effect of High-intensity Intermittent Training Program on Mood State in Overweight/Obese Young Men. Iran J Public Health (2016) 0.75

Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes. Physiol Behav (2016) 0.75

BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology. Psychopharmacology (Berl) (2016) 0.75

The Acute Effects of Exercise Intensity on Inhibitory Cognitive Control in Adolescents. Front Psychol (2017) 0.75

Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. J Physiol Biochem (2017) 0.75

Articles by these authors

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 10.05

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol (2001) 2.22

Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem (2001) 2.19

Endocannabinoids. Eur J Pharmacol (1998) 2.17

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol (2001) 2.15

The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem (2001) 2.13

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett (2000) 2.11

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 2.07

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond) (2007) 1.85

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol (1998) 1.83

The use of cryotherapy in sports injuries. Sports Med (1987) 1.80

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J (2005) 1.80

Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients. Diabetologia (2009) 1.74

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem (1997) 1.72

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol (2001) 1.67

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun (1999) 1.58

Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. FEBS Lett (1995) 1.57

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J (1997) 1.57

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J (2000) 1.55

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol (2001) 1.54

Anandamide may mediate sleep induction. Nature (1997) 1.53

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A (1998) 1.53

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? Curr Med Chem (1999) 1.51

Scapular-focused treatment in patients with shoulder impingement syndrome: a randomized clinical trial. Clin Rheumatol (2012) 1.49

Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex (2007) 1.45

Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse (1999) 1.44

Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J (2000) 1.44

The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem (2001) 1.43

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A (2001) 1.41

Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J Pharmacol Exp Ther (2004) 1.38

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem Biophys Res Commun (1999) 1.35

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology (2000) 1.34

Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem (2000) 1.34

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun (1998) 1.32

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett (2001) 1.30

New perspectives on enigmatic vanilloid receptors. Trends Neurosci (2000) 1.28

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia (2009) 1.28

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br J Pharmacol (2007) 1.28

Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience (2011) 1.28

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci (2006) 1.28

Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun (1997) 1.27

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett (1999) 1.27

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci (2007) 1.20

Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol (2001) 1.17

The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur J Biochem (2001) 1.17

The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone (2008) 1.16

Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) (2006) 1.16

Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol (2007) 1.15

Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch Biochem Biophys (2001) 1.15

Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J Neurosci (2003) 1.15

Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem Biophys Res Commun (2000) 1.15

Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci (2001) 1.13

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol (2007) 1.13

Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci (2003) 1.12

Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot Essent Fatty Acids (1995) 1.10

Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience (2007) 1.09

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci (2004) 1.09

Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine. Bioorg Med Chem Lett (2001) 1.07

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol (2000) 1.06

Commuter cycling: effect on physical performance in untrained men and women in Flanders: minimum dose to improve indexes of fitness. Scand J Med Sci Sports (2008) 1.04

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. Chem Phys Lipids (2000) 1.04

Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. Br J Pharmacol (2008) 1.04

Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01

Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol (2001) 1.01

Determining the intensity and energy expenditure during commuter cycling. Br J Sports Med (2006) 1.01

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf) (2011) 1.01

Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids (2006) 1.01

The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. Biochem Biophys Res Commun (1997) 1.00

Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia (2011) 1.00

Cycling to work: influence on indexes of health in untrained men and women in Flanders. Coronary heart disease and quality of life. Scand J Med Sci Sports (2007) 1.00

Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J Neurochem (1999) 0.99

Scapular positioning and movement in unimpaired shoulders, shoulder impingement syndrome, and glenohumeral instability. Scand J Med Sci Sports (2011) 0.98

Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res (2009) 0.96

Current knowledge on playing football in hot environments. Scand J Med Sci Sports (2010) 0.96

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. Eur J Biochem (1998) 0.95

Consensus recommendations on training and competing in the heat. Scand J Med Sci Sports (2015) 0.95

Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. Mol Hum Reprod (2004) 0.95

The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J Neurochem (2005) 0.95

Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. Neuropharmacology (2011) 0.94

Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience (1999) 0.94

Validity and reliability in a Flemish population of the WHO-MONICA Optional Study of Physical Activity Questionnaire. Med Sci Sports Exerc (1998) 0.93

Investigation of the structure/activity relationship of human calcitonin gene-related peptide (CGRP). Biochem Biophys Res Commun (1986) 0.93

Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist. Minerva Med (2011) 0.92

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. Cell Death Dis (2013) 0.92

Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol (1985) (2003) 0.92

Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003. Br J Sports Med (2007) 0.92

Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy (2009) 0.91

Cannabinoid properties of methylfluorophosphonate analogs. J Pharmacol Exp Ther (2000) 0.91

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J (2001) 0.91

Diagnosing overtraining in athletes using the two-bout exercise protocol. Br J Sports Med (2008) 0.90

Comparative biology of the endocannabinoid system possible role in the immune response. Eur J Biochem (2000) 0.90

Structure-activity relationship of human calcitonin-gene-related peptide. Biochem J (1990) 0.90

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiol Dis (2009) 0.90

Physiological and technical aspects of ''6-a-side'' soccer drills. J Sports Med Phys Fitness (2006) 0.90

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. Gut (2006) 0.89

Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow. J Biol Chem (1988) 0.89

Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park". J Biol Chem (1987) 0.89